Impact of Concomitant 5-Aminosalicylic Acid Therapy on Vedolizumab Efficacy and Safety in Inflammatory Bowel Disease: Post Hoc Analyses of Clinical Trial Data.
Ryan C UngaroHarisha KadaliWenwen ZhangShashi AdsulWalter ReinischPublished in: Journal of Crohn's & colitis (2023)
Continuation of concomitant oral 5-ASA after starting vedolizumab had no significant impact on clinical and endoscopic outcomes.